These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Predictors of methotrexate response in Turkish children with oligoarticular and polyarticular juvenile idiopathic arthritis. Batu ED, Sönmez HE, Gülhan B, Arıcı ZS, Topaloğlu R, Bilginer Y. Turk J Pediatr; 2017 Nov; 59(1):6-12. PubMed ID: 29168357 [Abstract] [Full Text] [Related]
5. Factors determining resistance to conventional disease-modifying anti-rheumatic drug treatment in oligoarticular juvenile idiopathic arthritis. Sener S, Aliyev E, Batu ED, Balik Z, Bayindir Y, Cam V, Basaran O, Bilginer Y, Ozen S. Clin Rheumatol; 2024 Jun; 43(6):2021-2026. PubMed ID: 38683443 [Abstract] [Full Text] [Related]
9. Outcome of children with oligoarticular juvenile idiopathic arthritis compared to polyarthritis on methotrexate- data of the German BIKER registry. Raab A, Kallinich T, Huscher D, Foeldvari I, Weller-Heinemann F, Dressler F, Kuemmerle-Deschner JB, Klein A, Horneff G. Pediatr Rheumatol Online J; 2021 Mar 22; 19(1):41. PubMed ID: 33752685 [Abstract] [Full Text] [Related]
11. The extended oligoarticular subtype is the best predictor of methotrexate efficacy in juvenile idiopathic arthritis. Ravelli A, Viola S, Migliavacca D, Ruperto N, Pistorio A, Martini A. J Pediatr; 1999 Sep 22; 135(3):316-20. PubMed ID: 10484796 [Abstract] [Full Text] [Related]
12. Dynamics of concomitant therapy in children with juvenile idiopathic arthritis treated with etanercept and methotrexate. Alexeeva E, Dvoryakovskaya T, Denisova R, Sleptsova T, Isaeva K, Chomahidze A, Fetisova A, Mamutova A, Alshevskaya A, Gladkikh V, Moskalev A. Pediatr Neonatol; 2019 Oct 22; 60(5):549-555. PubMed ID: 30885783 [Abstract] [Full Text] [Related]
15. Randomized, placebo-controlled, crossover trial of low-dose oral methotrexate in children with extended oligoarticular or systemic arthritis. Woo P, Southwood TR, Prieur AM, Doré CJ, Grainger J, David J, Ryder C, Hasson N, Hall A, Lemelle I. Arthritis Rheum; 2000 Aug 22; 43(8):1849-57. PubMed ID: 10943876 [Abstract] [Full Text] [Related]
16. Recommendations for the use of methotrexate in juvenile idiopathic arthritis. Niehues T, Lankisch P. Paediatr Drugs; 2006 Aug 22; 8(6):347-56. PubMed ID: 17154642 [Abstract] [Full Text] [Related]
17. Intra-articular corticosteroids versus intra-articular corticosteroids plus methotrexate in oligoarticular juvenile idiopathic arthritis: a multicentre, prospective, randomised, open-label trial. Ravelli A, Davì S, Bracciolini G, Pistorio A, Consolaro A, van Dijkhuizen EHP, Lattanzi B, Filocamo G, Verazza S, Gerloni V, Gattinara M, Pontikaki I, Insalaco A, De Benedetti F, Civino A, Presta G, Breda L, Marzetti V, Pastore S, Magni-Manzoni S, Maggio MC, Garofalo F, Rigante D, Gattorno M, Malattia C, Picco P, Viola S, Lanni S, Ruperto N, Martini A, Italian Pediatric Rheumatology Study Group. Lancet; 2017 Mar 04; 389(10072):909-916. PubMed ID: 28162781 [Abstract] [Full Text] [Related]
18. Prediction of methotrexate intolerance in juvenile idiopathic arthritis: a prospective, observational cohort study. van Dijkhuizen EH, Bulatović Ćalasan M, Pluijm SM, de Rotte MC, Vastert SJ, Kamphuis S, de Jonge R, Wulffraat NM. Pediatr Rheumatol Online J; 2015 Mar 04; 13():5. PubMed ID: 25745368 [Abstract] [Full Text] [Related]